<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Tamanini, F.</title>
    <link>http://repub.eur.nl/res/aut/2400/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Flexible phase adjustment of circadian albumin D site-binding protein (Dbp) gene expression by CRYPTOCHROME1 (Article)</title>
      <link>http://repub.eur.nl/res/pub/20313/</link>
      <pubDate>2010-06-15T00:00:00Z</pubDate>
      <description>The albumin D site-binding protein (DBP) governs circadian transcription of a number of hepatic detoxification and metabolic enzymes prior to the activity phase and subsequent food intake of mice. However, the behavior of mice is drastically affected by the photoperiod. Therefore, continuous adjustment of the phase of circadian Dbp expression is required in the liver. Here we describe a direct impact of CRYPTOCHROME1 (CRY1) on the phase of Dbp expression. Dbp and the nuclear receptor Rev-Erbα are circadian target genes of BMAL1 and CLOCK. Surprisingly, dynamic CRY1 binding to the Dbp promoter region delayed BMAL1 and CLOCK-mediated transcription of Dbp compared with Rev-Erbα. Extended presence of CRY1 in the nucleus enabled continuous uncoupling of the phase of Dbp from Rev-Erbα expression upon change from short to longer photoperiods. CRY1 thus maintained the peak of DBP accumulation close to the activity phase. In contrast, Rev-Erbα expression was phase-locked to the circadian oscillator and shaped by accumulation of its own gene product. Our data indicate that fine-tuning of circadian transcription in the liver is even more sophisticated than expected.</description>
    </item> <item>
      <title>Impact of the circadian clock on in vitro genotoxic risk assessment assays (Article)</title>
      <link>http://repub.eur.nl/res/pub/17306/</link>
      <pubDate>2009-11-01T00:00:00Z</pubDate>
      <description>Our society expects safety assessment for drugs, chemicals, cosmetics, and foods, which to date cannot be achieved without the use of laboratory animals. At the same time, society aims at refining, reducing, and (ultimately) replacing animal testing. As a consequence, much effort is taken to establish alternatives, such as toxicogenomics-based risk assessment assays on cultured cells and tissues. Evidently, the properties of cells in vitro will considerably differ from the in vivo situation. This review will discuss the impact of the circadian clock, an internal time keeping system that drives 24-h rhythms in metabolism, physiology and behavior, on in vitro genotoxic risk assessment. Our recent observation that DNA damaging agents can synchronize the circadian clock of individual cells in culture (and as a consequence the cyclic expression of clock-controlled genes, comprising up to 10% of the transcriptome) implies that the circadian clock should not be neglected when developing cell or tissue-based alternatives for chronic rodent toxicity assays.</description>
    </item> <item>
      <title>Fragile X-Related Proteins Regulate Mammalian Circadian Behavioral Rhythms (Article)</title>
      <link>http://repub.eur.nl/res/pub/28858/</link>
      <pubDate>2008-07-11T00:00:00Z</pubDate>
      <description>Fragile X syndrome results from the absence of the fragile X mental retardation 1 (FMR1) gene product (FMRP). FMR1 has two paralogs in vertebrates: fragile X related gene 1 and 2 (FXR1 and FXR2). Here we show that Fmr1/Fxr2 double knockout (KO) and Fmr1 KO/Fxr2 heterozygous animals exhibit a loss of rhythmic activity in a light:dark (LD) cycle, and that Fmr1 or Fxr2 KO mice display a shorter free-running period of locomotor activity in total darkness (DD). Molecular analysis and in vitro electrophysiological studies suggest essentially normal function of cells in the suprachiasmatic nucleus (SCN) in Fmr1/Fxr2 double KO mice. However, the cyclical patterns of abundance of several core clock component messenger (m) RNAs are altered in the livers of double KO mice. Furthermore, FXR2P alone or FMRP and FXR2P together can increase PER1- or PER2-mediated BMAL1-Neuronal PAS2 (NPAS2) transcriptional activity in a dose-dependent manner. These data collectively demonstrate that FMR1 and FXR2 are required for the presence of rhythmic circadian behavior in mammals and suggest that this role may be relevant to sleep and other behavioral alterations observed in fragile X patients. </description>
    </item> <item>
      <title>Phase Resetting of the Mammalian Circadian Clock by DNA Damage (Article)</title>
      <link>http://repub.eur.nl/res/pub/30014/</link>
      <pubDate>2008-02-26T00:00:00Z</pubDate>
      <description>To anticipate the momentum of the day, most organisms have developed an internal clock that drives circadian rhythms in metabolism, physiology, and behavior [1]. Recent studies indicate that cell-cycle progression and DNA-damage-response pathways are under circadian control [2-4]. Because circadian output processes can feed back into the clock, we investigated whether DNA damage affects the mammalian circadian clock. By using Rat-1 fibroblasts expressing an mPer2 promoter-driven luciferase reporter, we show that ionizing radiation exclusively phase advances circadian rhythms in a dose- and time-dependent manner. Notably, this in vitro finding translates to the living animal, because ionizing radiation also phase advanced behavioral rhythms in mice. The underlying mechanism involves ATM-mediated damage signaling as radiation-induced phase shifting was suppressed in fibroblasts from cancer-predisposed ataxia telangiectasia and Nijmegen breakage syndrome patients. Ionizing radiation-induced phase shifting depends on neither upregulation or downregulation of clock gene expression nor on de novo protein synthesis and, thus, differs mechanistically from dexamethasone- and forskolin-provoked clock resetting [5]. Interestingly, ultraviolet light and tert-butyl hydroperoxide also elicited a phase-advancing effect. Taken together, our data provide evidence that the mammalian circadian clock, like that of the lower eukaryote Neurospora [6], responds to DNA damage and suggest that clock resetting is a universal property of DNA damage. </description>
    </item> <item>
      <title>Light Entrainment of the Mammalian Circadian Clock by a PRKCA-Dependent Posttranslational Mechanism (Article)</title>
      <link>http://repub.eur.nl/res/pub/36274/</link>
      <pubDate>2007-06-07T00:00:00Z</pubDate>
      <description>Light is the most potent stimulus for synchronizing endogenous circadian rhythms with external time. Photic clock resetting in mammals involves cAMP-responsive element binding protein (CREB)-mediated transcriptional activation of Period clock genes in the suprachiasmatic nuclei (SCN). Here we provide evidence for an additional photic input pathway to the mammalian circadian clock based on Protein Kinase C α (PRKCA). We found that Prkca-deficient mice show an impairment of light-mediated clock resetting. In the SCN of wild-type mice, light exposure evokes a transient interaction between PRKCA and PERIOD 2 (PER2) proteins that affects PER2 stability and nucleocytoplasmic distribution. These posttranslational events, together with CREB-mediated transcriptional regulation, are key factors in the molecular mechanism of photic clock resetting. </description>
    </item> <item>
      <title>Functional evolution of the photolyase/cryptochrome protein family: importance of the C terminus of mammalian CRY1 for circadian core oscillator performance. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13981/</link>
      <pubDate>2006-03-01T00:00:00Z</pubDate>
      <description>Cryptochromes (CRYs) are composed of a core domain with structural similarity to photolyase and a distinguishing C-terminal extension. While plant and fly CRYs act as circadian photoreceptors, using the C terminus for light signaling, mammalian CRY1 and CRY2 are integral components of the circadian oscillator. However, the function of their C terminus remains to be resolved. Here, we show that the C-terminal extension of mCRY1 harbors a nuclear localization signal and a putative coiled-coil domain that drive nuclear localization via two independent mechanisms and shift the equilibrium of shuttling mammalian CRY1 (mCRY1)/mammalian PER2 (mPER2) complexes towards the nucleus. Importantly, deletion of the complete C terminus prevents mCRY1 from repressing CLOCK/BMAL1-mediated transcription, whereas a plant photolyase gains this key clock function upon fusion to the last 100 amino acids of the mCRY1 core and its C terminus. Thus, the acquirement of different (species-specific) C termini during evolution not only functionally separated cryptochromes from photolyase but also caused diversity within the cryptochrome family.</description>
    </item> <item>
      <title>Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13054/</link>
      <pubDate>2002-03-15T00:00:00Z</pubDate>
      <description>The core oscillator generating circadian rhythms in eukaryotes is composed of transcription--translation-based autoregulatory feedback loops in which clock gene products negatively affect their own expression. A key step in this mechanism involves the periodic nuclear accumulation of clock proteins following their mRNA rhythms after approximately 6 h delay. Nuclear accumulation of mPER2 is promoted by mCRY proteins. Here, using COS7 cells and mCry1/mCry2 double mutant mouse embryonic fibroblasts transiently expressing GFP-tagged (mutant) mPER2, we show that the protein shuttles between nucleus and cytoplasm using functional nuclear localization and nuclear export sequences. Moreover, we provide evidence that mCRY proteins prevent ubiquitylation of mPER2 and subsequent degradation of the latter protein by the proteasome system. Interestingly, mPER2 in turn prevents ubiquitylation and degradation of mCRY proteins. On the basis of these data we propose a model in which shuttling mPER2 is ubiquitylated and degraded by the proteasome unless it is retained in the nucleus by mCRY proteins.</description>
    </item> <item>
      <title>Dimerization and nuclear entry of mPER proteins in mammalian cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/9377/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Nuclear entry of circadian oscillatory gene products is a key step for the
      generation of a 24-hr cycle of the biological clock. We have examined
      nuclear import of clock proteins of the mammalian period gene family and
      the effect of serum shock, which induces a synchronous clock in cultured
      cells. Previously, mCRY1 and mCRY2 have been found to complex with PER
      proteins leading to nuclear import. Here we report that nuclear
      translocation of mPER1 and mPER2 (1) involves physical interactions with
      mPER3, (2) is accelerated by serum treatment, and (3) still occurs in
      mCry1/mCry2 double-deficient cells lacking a functional biological clock.
      Moreover, nuclear localization of endogenous mPER1 was observed in
      cultured mCry1/mCry2 double-deficient cells as well as in the liver and
      the suprachiasmatic nuclei (SCN) of mCry1/mCry2 double-mutant mice. This
      indicates that nuclear translocation of at least mPER1 also can occur
      under physiological conditions (i.e., in the intact mouse) in the absence
      of any CRY protein. The mPER3 amino acid sequence predicts the presence of
      a cytoplasmic localization domain (CLD) and a nuclear localization signal
      (NLS). Deletion analysis suggests that the interplay of the CLD and NLS
      proposed to regulate nuclear entry of PER in Drosophila is conserved in
      mammals, but with the novel twist that mPER3 can act as the dimerizing
      partner.</description>
    </item> <item>
      <title>The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins (Article)</title>
      <link>http://repub.eur.nl/res/pub/9408/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Fragile X syndrome is caused by the absence of the fragile X
          mental-retardation protein (FMRP). FMRP and the fragile X-related proteins
          1 and 2 (FXR1P and FXR2P) form a gene family with functional similarities,
          such as RNA binding, polyribosomal association and nucleocytoplasmic
          shuttling. In a previous study, we found that FMRP and FXR1P shuttle
          between cytoplasm and nucleoplasm, while FXR2P shuttles between cytoplasm
          and nucleolus. The nuclear and nucleolar-targeting properties of these
          proteins were investigated further. Here, we show that FXR2P contains in
          its C-terminal part, a stretch of basic amino acids 'RPQRRNRSRRRRFR' that
          resemble the nucleolar-targeting signal (NoS) of the viral protein Rev.
          This particular sequence is also present within exon 15 of the FXR1 gene.
          This exon undergoes alternative splicing and is therefore only present in
          some of the FXR1P isoforms. We investigated the intracellular distribution
          of various FXR1P isoforms with (iso-e and iso-f) and without (iso-d) the
          potential NoS in transfected COS cells treated with the nuclear export
          inhibitor leptomycin-B. Both iso-e and iso-f showed a nucleolar
          localization, as observed for FXR2P; iso-d was detected in the
          nucleo-plasm outside the nucleoli. Further, when a labelled 16-residue
          synthetic peptide corresponding to the NoS of FXR1P was added to human
          fibroblast cultures a clear nucleolar signal was observed. Based on these
          data we argue that the intranuclear distribution of FXR2P and FXR1P
          isoforms is very likely to be mediated by a similar NoS localized in their
          C-terminal region. This domain is absent in some FXR1P isoforms as well as
          in all FMRP isoforms, suggesting functional differences for this family of
          proteins, possibly related to RNA metabolism in different tissues.</description>
    </item> <item>
      <title>The Role of the FMRI Protein Involved in Fragle X-Syndrome (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/15790/</link>
      <pubDate>1999-06-30T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations (Article)</title>
      <link>http://repub.eur.nl/res/pub/9073/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Fragile X syndrome is caused by the absence of the fragile X mental
          retardation protein (FMRP). FMRP and its structural homologues FXR1P and
          FXR2P form a family of RNA-binding proteins (FXR proteins). The three
          proteins associate with polyribosomes as cytoplasmic mRNP particles. Here
          we show that small amounts of FMRP, FXR1P and FXR2P shuttle between
          cytoplasm and nucleus. Mutant FMRP of a severely affected fragile X
          patient (FMRPI304N) does not associate with polyribosomes and shuttles
          more frequently than normal FMRP, indicating that the association with
          polyribosomes regulates the shuttling process. Using leptomycin B we
          demonstrate that transport of the FXR proteins out of the nucleus is
          mediated by the export receptor exportin1. Finally, inactivation of the
          nuclear export signal in two FXR proteins shows that FMRP shuttles between
          cytoplasm and nucleoplasm, while FXR2P shuttles between cytoplasm and
          nucleolus. Therefore, molecular dissection of the shuttling routes used by
          the FXR proteins suggests that they transport different RNAs.</description>
    </item> <item>
      <title>Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P (Article)</title>
      <link>http://repub.eur.nl/res/pub/9181/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>The absence of fragile-X mental-retardation protein (FMRP) results in
          fragile-X syndrome. Two other fragile-X-related (FXR) proteins have been
          described, FXR1P and FXR2P, which are both very similar in amino acid
          sequence to FMRP. Interaction between the three proteins as well as with
          themselves has been demonstrated. The FXR proteins are believed to play a
          role in RNA metabolism. To characterize a possible functional role of the
          interacting proteins the complex formation of the FXR proteins was studied
          in mammalian cells. Double immunofluorescence analysis in COS cells
          over-expressing either FMRP ISO12/FXR1P or FMRP ISO12/FXR2P confirmed
          heterotypic interactions. However, Western-blotting studies on cellular
          homogenates containing physiological amounts of the three proteins gave
          different indications. Gel-filtration experiments under physiological as
          well as EDTA conditions showed that the FXR proteins were in complexes of
          &gt;600 kDa, as parts of messenger ribonuclear protein (mRNP) particles
          associated with polyribosomes. Salt treatment shifted FMRP, FXR1P and
          FXR2P into distinct intermediate complexes, with molecular masses between
          200 and 300 kDa. Immunoprecipitations of FMRP as well as FXR1P from the
          dissociated complexes revealed that the vast majority of the FXR proteins
          do not form heteromeric complexes. Further analysis by [(35)S]methionine
          labelling in vivo followed by immunoprecipitation indicated that no
          proteins other than the FXR proteins were present in these complexes.
          These results suggest that the FXR proteins form homo-multimers
          preferentially under physiological conditions in mammalian cells, and
          might participate in mRNP particles with separate functions.</description>
    </item> <item>
      <title>Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis (Article)</title>
      <link>http://repub.eur.nl/res/pub/8709/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>Lack of expression of the fragile X mental retardation protein (FMRP)
      results in mental retardation and macroorchidism, seen as the major
      pathological symptoms in fragile X patients. FMRP is a cytoplasmic
      RNA-binding protein which cosediments with the 60S ribosomal subunit.
      Recently, two proteins homologous to FMRP were discovered: FXR1 and FXR2.
      These novel proteins interact with FMRP and with each other and they are
      also associated with the 60S ribosomal subunit. Here, we studied the
      expression pattern of the three proteins in brain and testis by
      immunohistochemistry. In adult brain, FMR1, FXR1 and FXR2 proteins are
      coexpressed in the cytoplasm of specific differentiated neurons only.
      However, we observed a different expression pattern in fetal brain as well
      as in adult and fetal testis, suggesting independent functions for the
      three proteins in those tissues during embryonic development and adult
      life.</description>
    </item> <item>
      <title>FMRP is associated to the ribosomes via RNA (Article)</title>
      <link>http://repub.eur.nl/res/pub/8620/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>The FMR1 transcript is alternatively spliced and generates different
      splice variants coding for FMR1 proteins (FMRP) with a predicted molecular
      mass of 70-80 kDa. FMRP is widely expressed and localized in the
      cytoplasm. To study a possible interaction with other cellular components,
      FMRP was isolated and characterized under non-denaturing conditions. Under
      physiological salt conditions FMRP appears to have a molecular mass of &gt;
      600 kDa, indicating a binding to other cellular components. This
      interaction is disrupted in the presence of high salt concentrations. The
      dissociation conditions to free FMRP from the complex are similar to the
      dissociation of FMRP from RNA as shown before. The binding of FMRP from
      the complex is also disrupted by RNAse treatment. That the association of
      FMRP to a high molecular weight complex possibly occurs via RNA, is
      further supported by the observation that the binding of FMRP, containing
      an lle304Asn substitution, to the high molecular weight complex is
      reduced. An equal reduced binding of mutated FMRP to RNA in vitro was
      observed before under the same conditions. The reduced binding of FMRP
      with the lle304Asn substitution further indicates that the interaction to
      the complex indeed occurs via FMRP and not via other RNA binding proteins.
      In a reconstitution experiment where the low molecular mass FMRP (70-80
      kDa) is mixed with a reticulocyte lysate (enriched in ribosomes) it was
      shown that FMRP can associate to ribosomes and that this binding most
      likely occurs via RNA.</description>
    </item>
  </channel>
</rss>